These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29955039)

  • 1. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.
    Cappella M; Perfetti A; Cardinali B; Garcia-Manteiga JM; Carrara M; Provenzano C; Fuschi P; Cardani R; Renna LV; Meola G; Falcone G; Martelli F
    Cell Death Dis; 2018 Jun; 9(7):729. PubMed ID: 29955039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-mRNA expression profiles in the skeletal muscle of myotonic dystrophy type 1.
    Li M; Li Y; Wang Z; Cui F; Yang F; Wang H; Shi Q; Huang X
    Neurol Res; 2024 Jul; 46(7):613-625. PubMed ID: 38810890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.
    Fernandez-Costa JM; Garcia-Lopez A; Zuñiga S; Fernandez-Pedrosa V; Felipo-Benavent A; Mata M; Jaka O; Aiastui A; Hernandez-Torres F; Aguado B; Perez-Alonso M; Vilchez JJ; Lopez de Munain A; Artero RD
    Hum Mol Genet; 2013 Feb; 22(4):704-16. PubMed ID: 23139243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.
    Gambardella S; Rinaldi F; Lepore SM; Viola A; Loro E; Angelini C; Vergani L; Novelli G; Botta A
    J Transl Med; 2010 May; 8():48. PubMed ID: 20487562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1.
    Perbellini R; Greco S; Sarra-Ferraris G; Cardani R; Capogrossi MC; Meola G; Martelli F
    Neuromuscul Disord; 2011 Feb; 21(2):81-8. PubMed ID: 21169019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1.
    Voellenkle C; Perfetti A; Carrara M; Fuschi P; Renna LV; Longo M; Sain SB; Cardani R; Valaperta R; Silvestri G; Legnini I; Bozzoni I; Furling D; Gaetano C; Falcone G; Meola G; Martelli F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of microRNAs in blood and skeletal muscles of myotonic dystrophy type 1 patients.
    Ambrose KK; Ishak T; Lian LH; Goh KJ; Wong KT; Ahmad-Annuar A; Thong MK
    Neurol India; 2017; 65(3):512-517. PubMed ID: 28488611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE; González-Barriga A; van den Broek WJ; Wieringa B; Wansink DG
    Hum Mol Genet; 2016 Apr; 25(8):1648-62. PubMed ID: 26908607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
    Cerro-Herreros E; Sabater-Arcis M; Fernandez-Costa JM; Moreno N; Perez-Alonso M; Llamusi B; Artero R
    Nat Commun; 2018 Jun; 9(1):2482. PubMed ID: 29946070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microRNAs as biomarkers for myotonic dystrophy type 1.
    Perfetti A; Greco S; Bugiardini E; Cardani R; Gaia P; Gaetano C; Meola G; Martelli F
    Neuromuscul Disord; 2014 Jun; 24(6):509-15. PubMed ID: 24679513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.
    Fritegotto C; Ferrati C; Pegoraro V; Angelini C
    Neurol Sci; 2017 Apr; 38(4):619-625. PubMed ID: 28078570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated microRNAs in myotonic dystrophy type 2.
    Greco S; Perfetti A; Fasanaro P; Cardani R; Capogrossi MC; Meola G; Martelli F
    PLoS One; 2012; 7(6):e39732. PubMed ID: 22768114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.
    Kalsotra A; Singh RK; Gurha P; Ward AJ; Creighton CJ; Cooper TA
    Cell Rep; 2014 Jan; 6(2):336-45. PubMed ID: 24412363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.
    Ravel-Chapuis A; Bélanger G; Côté J; Michel RN; Jasmin BJ
    Hum Mol Genet; 2017 Jun; 26(12):2192-2206. PubMed ID: 28369518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulations of miR-1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1.
    Souidi A; Nakamori M; Zmojdzian M; Jagla T; Renaud Y; Jagla K
    EMBO Rep; 2023 Apr; 24(4):e56616. PubMed ID: 36852954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.